T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
iShares MSCI India ETF
INDA
$9.4B
| $11.4M | ﹤0.01% |
272,872
-2,800
| -1% | -$117K |
|
1027
Dynatrace
DT
$14.8B
| $11.2M | ﹤0.01% |
291,678
+5,099
| +2% | +$195K |
|
1028
Zions Bancorporation
ZION
$8.6B
| $11.2M | ﹤0.01% |
226,892
-352
| -0.2% | -$17.3K |
|
|
LUXE
1029
LuxExperience B.V. American Depositary Shares, each representing one Ordinary Share
LUXE
$1.27B
| $11.1M | ﹤0.01% |
1,247,962
-15,228
| -1% | -$136K |
|
|
NVRO
1030
DELISTED
NEVRO CORP.
NVRO
| $11.1M | ﹤0.01% |
280,434
-10,099
| -3% | -$400K |
|
1031
Certara
CERT
$1.75B
| $11.1M | ﹤0.01% |
689,248
-268,337
| -28% | -$4.31M |
|
1032
F5
FFIV
$19.2B
| $10.9M | ﹤0.01% |
76,255
-1,700
| -2% | -$244K |
|
1033
NRG Energy
NRG
$30.5B
| $10.9M | ﹤0.01% |
343,138
-1,952
| -0.6% | -$62.1K |
|
1034
Genmab
GMAB
$17.6B
| $10.6M | ﹤0.01% |
251,098
-1,100
| -0.4% | -$46.6K |
|
1035
American Airlines Group
AAL
$8.54B
| $10.6M | ﹤0.01% |
835,301
+7,606
| +0.9% | +$96.7K |
|
1036
FIVE9
FIVN
$2.02B
| $10.6M | ﹤0.01% |
156,344
-1,719,842
| -92% | -$117M |
|
1037
LCI Industries
LCII
$2.52B
| $10.6M | ﹤0.01% |
114,724
-39,863
| -26% | -$3.69M |
|
1038
Reinsurance Group of America
RGA
$12.9B
| $10.5M | ﹤0.01% |
74,218
+36,923
| +99% | +$5.25M |
|
1039
W.P. Carey
WPC
$15B
| $10.5M | ﹤0.01% |
137,764
+22,236
| +19% | +$1.7M |
|
|
ALLK
1040
DELISTED
Allakos
ALLK
| $10.5M | ﹤0.01% |
1,250,433
+451,058
| +56% | +$3.8M |
|
1041
FTI Consulting
FCN
$5.4B
| $10.5M | ﹤0.01% |
66,072
-27,286
| -29% | -$4.33M |
|
1042
Hasbro
HAS
$11.2B
| $10.5M | ﹤0.01% |
171,625
-2,207
| -1% | -$135K |
|
1043
Arcus Biosciences
RCUS
$1.22B
| $10.5M | ﹤0.01% |
505,747
+481,848
| +2,016% | +$9.96M |
|
1044
Whirlpool
WHR
$5.31B
| $10.4M | ﹤0.01% |
73,636
-437
| -0.6% | -$61.8K |
|
1045
Brunswick
BC
$4.36B
| $10.3M | ﹤0.01% |
143,057
-9,885
| -6% | -$713K |
|
|
DCPH
1046
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $10.2M | ﹤0.01% |
624,887
-91,870
| -13% | -$1.51M |
|
1047
Prestige Consumer Healthcare
PBH
$3.2B
| $10.2M | ﹤0.01% |
163,218
+111,046
| +213% | +$6.95M |
|
1048
Carnival Corp
CCL
$44B
| $10.2M | ﹤0.01% |
1,264,656
+12,533
| +1% | +$101K |
|
1049
Gibraltar Industries
ROCK
$1.84B
| $10.1M | ﹤0.01% |
220,055
-51,949
| -19% | -$2.38M |
|
|
BCYC
1050
Bicycle Therapeutics
BCYC
$487M
| $10M | ﹤0.01% |
338,733
-78,607
| -19% | -$2.33M |
|